Our 8th IKCC Conference for kidney cancer patient organisations recently held in Mexico City, Mexico was a huge success with over 50 kidney cancer patient advocates from 25 countries attending . Throughout the three-day meeting patient organisation leaders learned about latest developments in kidney cancer care, discussed active patient involvement and shared experiences with national healthcare policies. This meeting was held alongside a Clinical Experts meeting hosted by the <a href="http://www.larcg.org/
7th Expanding Circles 2017 Annual Conference of the International Kidney Cancer Coalition (IKCC): Dr. Eric Jonasch and Dr. Lizzie Perdeaux elected to Board of Directors
The International Kidney Cancer Coalition (IKCC) completed its 7th Expanding Circles 2017 Annual Conference from April 6th – 8th, 2017 in Warsaw, Poland and announces Dr. Eric Jonasch and Dr. Lizzie Perdeaux as new members of the Board of Directors.
Warsaw/Poland, April 20, 2017
The International Kidney Cancer Coalition (IKCC) held its “7th Expanding Circles 2017 Annual Conference – the International Conference for Organisations Representing Patients with Kidney Cancer” from April 6th-8th, 2017 in Warsaw
Our seventh IKCC Conference for kidney cancer patient organisations recently held in Warsaw, Poland was a huge success. The first ever Global Kidney Cancer Awareness Day – Thursday 22nd June 2017 – was officially launched following the keynote address on the ‘Global Burden of Kidney Cancer’ delivered by Prof. Dr. Hendrik van Poppel of Belgium.
During the AGM, Dr. Eric Jonasch, an internationally recognized expert specialising in kidney cancer from Texas, USA and Dr. Elizabeth Perdeaux
Immuno-oncology (IO) therapy is a new (and old) way to treat cancer by activating your immune system in the hope that it will attack your tumour. Our sister site ‘10-for-IO’ is a central resource for patient organisations to access information about immuno-oncology specifically as it applies to renal cell carcinoma. Click here for more information.
7th International Kidney Cancer Coalition Conference
Warsaw, Poland 6th, 7th & 8th April 2017
Our seventh IKCC Conference for kidney cancer patient organisations will be held in Warsaw, Poland on 6th, 7th & 8th April 2017.
Our conference will bring together cancer patient group leaders from around the world to share best practices, exchange experiences and work together to improve the lives of kidney cancer patients wherever they live. Read more
The main goals of our conference will
Results from a phase 2 study of sonepcizumab were published in the journal Cancer this week and showed encouraging overall survival and a favourable safety profile, although the study did not reach its primary endpoint of 2-month progression-free survival (PFS). However, despite the modest PFS (mean of 2.2 months), the encouraging overall survival warrant further investigation of sonepcizumab in combination with immunotherapies and vascular endothelial growth factor (VEGF) inhibitors. <a href="http://www.healio.com/hematology-oncology/genitourinary-cancer/news/in-the-journals/%7B8d65ed95-3a09-4f92-bd0e-1487c53a7d19%7D/sonepcizumab-shows-promise-for-metastatic-renal-cell-carcinoma